Midas Pharma Gmbh
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 1988-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.midas-pharma.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
4
EMA:2
CIMA_AEMPS:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Ramipril, Amlodipine and Atorvastatin
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Midas Pharma GmbH
- Target Recruit Count
- 18
- Registration Number
- NCT04262765
- Locations
- 🇯🇴
International Pharmaceutical Research Center, Amman, Jordan
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Midas Pharma GmbH
- Target Recruit Count
- 18
- Registration Number
- NCT04245046
- Locations
- 🇯🇴
International Pharmaceutical Research Center, Amman, Jordan
News
No news found